Capgemini Invent published an article exploring the four structural drivers behind declining R&D productivity, how AI, CRISPR, and Real-World Evidence are beginning to reverse the trend, and why an integrated technology stack is key to accelerating drug discovery and development.

Capgemini Invent is the digital innovation, consulting and transformation brand of the Capgemini Group, a global business line that combines market leading expertise in strategy, technology, data science and creative design, to help CxOs envision and build what’s next for their businesses. For more information: http://www.capgemini.com/invent. Follow us on Twitter @CapgeminiInvent.